Kisspeptin — what the research says about the HPG hormonal axis regulator

Kisspeptin is a neuropeptide encoded by the KISS1 gene, an agonist of the KISS1R receptor (formerly GPR54), acting as the master regulator of the hypothalamic–pituitary–gonadal (HPG) axis. It is one of the most extensively clinically studied peptides in the context of fertility and sexual arousal. In laboratory trade it is available as a research reagent (Research Use Only).

When it comes to the control of mammalian reproduction, most accounts begin with the hypothalamic gonadotropin-releasing hormone (GnRH) — a peptide regarded for decades as the apex of the hormonal hierarchy. The discovery of the role of kisspeptin pushed that boundary one storey higher. It turned out that kisspeptin is precisely the peptide that acts as the master regulator — the signal that decides when GnRH neurons should “fire”. It has been called the “switch” of the reproductive axis, because without proper kisspeptin signalling the entire hormonal cascade remains silenced. Mutations of the kisspeptin receptor in humans are associated with an absence of sexual maturation, which from the outset demonstrated how fundamental a position this neuropeptide occupies in reproductive physiology.

Kisspeptin is at the same time one of the most extensively clinically studied peptides of the reproductive axis. Research teams — led by Waljit Dhillo’s group at Imperial College London — conducted a series of controlled studies on its influence on the secretion of sex hormones and on the central processing of stimuli related to sexual arousal. The article below is a review of this literature — without promises and without extrapolation. In the One Peptides catalogue, kisspeptin appears solely as a chemical reagent for laboratory research.

The article below is purely educational in nature and constitutes a review of the published scientific literature on kisspeptin. Some of the works cited are clinical studies conducted at academic centres (including Imperial College London) on the physiology of the reproductive axis. Citing these studies serves to describe the scientific mechanism — it does not constitute a recommendation or a suggestion to use kisspeptin in humans. In the European Union, kisspeptin is not registered as a medicine or a dietary supplement; in the One Peptides catalogue it is available solely as a chemical reagent for laboratory research (Research Use Only). This text does not constitute medical advice.

What is kisspeptin

Kisspeptin is a family of peptides arising from a precursor protein encoded by the KISS1 gene. From the precursor — a 145-amino-acid prepro-kisspeptin — proteolytic processing produces several active fragments of varying length: kisspeptin-54, kisspeptin-14, kisspeptin-13 and kisspeptin-10 (KP-10). All these forms share a common, biologically active C-terminus and all bind to the same receptor.

Kisspeptin-10 (Kisspeptin-10, KP-10) is the ten-amino-acid C-terminal fragment of the parent molecule. It is the shortest form retaining full biological activity — it is precisely this common C-terminal motif that is responsible for binding and activation of the receptor. For this reason, KP-10 has become a popular tool in research on kisspeptin signalling: a short sequence, simpler synthesis, and receptor activity comparable with the longer variants.

The receptor for kisspeptin is KISS1R, previously known as GPR54 (an orphan receptor whose ligand was identified only later). It is a G protein-coupled receptor (GPCR) whose activation triggers an intracellular cascade leading to the stimulation of GnRH-secreting neurons. KISS1R is found primarily on GnRH neurons in the hypothalamus, but expression of the gene is also detected in other tissues.

Kisspeptin occurs naturally in both sexes and plays a fundamental role in sexual maturation. Historically, the significance of this system was revealed when inactivating mutations of the receptor gene were identified in people with hypogonadotropic hypogonadism and an absence of spontaneous maturation. Without functional kisspeptin–KISS1R signalling, the reproductive axis does not “wake up” during puberty — which became one of the strongest pieces of evidence for the master position of this peptide in the hormonal hierarchy.

The hypothalamic–pituitary–gonadal (HPG) axis

To understand why kisspeptin is described as a “higher-order regulator”, one must trace how the entire reproductive axis works. The hypothalamic–pituitary–gonadal (HPG) axis is a hierarchical hormonal system in which the signal flows from the brain downwards, to the gonads, and the products of the gonads return as feedback.

The cascade can be described step by step:

1. KNDy neurons in the hypothalamus — within the arcuate nucleus of the hypothalamus there is a population of neurons named with the abbreviation KNDy, after the three substances co-occurring within them: Kisspeptin, Neurokinin B and Dynorphin. It is here that the rhythm is generated — the pulsatile pattern of activity that drives the entire axis. KNDy neurons release kisspeptin.
2. Stimulation of GnRH neurons — kisspeptin acts on the KISS1R receptors located on GnRH neurons, stimulating them to the pulsatile secretion of gonadotropin-releasing hormone (GnRH). Without this signal, GnRH neurons remain largely inactive. This is why kisspeptin is called the “switch” — it determines whether, and at what frequency, GnRH pulses are generated.
3. The pituitary and gonadotropins — GnRH reaches the anterior lobe of the pituitary via the portal circulation, where it stimulates the secretion of two gonadotropic hormones: luteinising hormone (LH) and follicle-stimulating hormone (FSH).
4. The gonads and sex hormones — LH and FSH act on the gonads. In men, LH stimulates the Leydig cells in the testes to produce testosterone, while FSH supports spermatogenesis. In women, the gonadotropins regulate the maturation of ovarian follicles, ovulation and the production of oestrogens and progesterone.
5. Feedback — sex hormones return as feedback, modulating the activity of the higher tiers of the axis, including the KNDy neurons themselves.

It is helpful to picture the mechanism as a control system with a central rhythm regulator. GnRH is the executor relaying the command to the pituitary, but it is kisspeptin that sets the rhythm and decides when the command is to be sent. This is precisely why research on kisspeptin is of such importance for understanding the entire physiology of reproduction — by modulating the highest tier, one can observe the response of the entire cascade downstream.

What the research says

Kisspeptin is among the few peptides of the reproductive axis to have received an extensive programme of controlled studies in humans — mainly at academic centres, within the paradigm of studying physiology, not registering a medicine. Below is a review of the main directions.

The reproductive axis and gonadotropin secretion. The best-documented effect observed in the studies is the influence of kisspeptin administration on the secretion of LH (and, to a lesser extent, FSH). In works involving healthy volunteers, the administration of kisspeptin was associated with an increase in the blood concentration of gonadotropins, which confirmed its role as a direct stimulator of the axis above the level of GnRH.

Hypothalamic amenorrhoea and fertility. The group of Channa Jayasena et al. studied kisspeptin in the context of disorders of the reproductive axis in women, including hypothalamic amenorrhoea — a condition in which the HPG axis is “silenced” despite a normal gonadal structure. The studies explored the ability of kisspeptin to stimulate the axis in situations of its underactivity, as well as its potential significance in the area of diagnostics and assisted reproduction.

The assisted-reproduction context (IVF). One of the most frequently described research applications was the role of kisspeptin as a stimulus triggering the maturation of oocytes in in vitro fertilisation protocols. Because kisspeptin acts “upstream” of the axis and leads to an endogenous LH surge, it was studied as an alternative to classical methods of triggering ovulation, with the prospect of a more favourable profile in selected groups of patients.

Sexual arousal and stimulus processing. The team of Alexander Comninos and Waljit Dhillo at Imperial College London conducted research on the influence of kisspeptin not only on hormones, but also on the central processing of stimuli related to sexual arousal. In brain-imaging studies (fMRI), a modulation of the activity of structures involved in the processing of emotions and stimuli of a sexual nature was observed after the administration of kisspeptin compared with placebo. This direction opened a discussion on the role of kisspeptin at the interface of the hormonal system and the central regulation of behaviour.

The table below organises the main directions of research.

It is worth emphasising the interpretive framework: some of the works cited are physiological studies on small groups, conducted under controlled conditions, assessing the acute response of the axis to administration of the peptide. These are not registration studies, nor material justifying use outside the laboratory.

Kisspeptin and testosterone

This is an area requiring particular precision, because it is sometimes reduced to a slogan that the literature does not confirm. Kisspeptin does not act on testosterone directly. It is neither a precursor of the hormone, nor a modulator of the androgen receptor, nor an aromatase inhibitor. Its relationship with testosterone is indirect and proceeds through the entire HPG axis.

The pathway is as follows: kisspeptin stimulates GnRH neurons → an increase in GnRH pulses → an increase in LH secretion by the pituitary → LH acts on the Leydig cells in the testes → the Leydig cells increase the production of testosterone. In other words, in the studies an influence of kisspeptin administration on LH secretion and indirectly on testosterone concentration was observed — an effect dependent on the functioning of all tiers of the axis.

This is a qualitatively different mechanism from that of direct hormonal modulators. Selective androgen receptor modulators (SARMs) act directly on the androgen receptor in target tissues, bypassing the entire axis. Exogenous testosterone supplies the hormone from outside while simultaneously silencing the axis through feedback. Kisspeptin acts in the opposite direction to this logic — it works “from the top”, through the physiological endogenous cascade, rather than by bypassing regulation.

Here honesty about the limitations of the evidence is essential. Most observations concerning LH and testosterone come from studies assessing the acute hormonal response — the short-term reaction to administration of the peptide under experimental conditions. From these data it does not follow that kisspeptin “raises testosterone” in the sense of a lasting change in the hormonal profile, nor that this translates in any way into clinically significant effects in healthy individuals. There is no basis for treating kisspeptin as a “natural testosterone booster” — such a framing is contrary to the literature and to the RUO character of this reagent. What the science describes is the role of kisspeptin as a tool for studying the physiology of the axis, not an agent for modifying hormones in humans.

Kisspeptin and PT-141

Kisspeptin and PT-141 (bremelanotide) are sometimes paired as “libido peptides”, which is misleading — they share an area of research interest, but differ in mechanism. These are two distinct signalling systems.

Kisspeptin acts hormonally, through the HPG axis. Its receptor is KISS1R/GPR54, and its biological effect is realised through the cascade GnRH → LH/FSH → sex hormones. The kisspeptin signal modifies the workings of the entire reproductive hormonal system, and the influence on the processing of sexual stimuli observed in the studies overlays this hormonal context.

PT-141 acts centrally, through the melanocortin system. Bremelanotide is an agonist of melanocortin receptors, mainly MC4R in the hypothalamus and brainstem. It does not pass through the HPG axis and does not change the gonadotropin profile — it modulates the motivational signal in centres of the central nervous system independently of the reproductive hormonal system.

In short: kisspeptin is a reproductive-axis peptide (hormonal, KISS1R receptor), PT-141 is a melanocortin peptide (central, MC4R receptor). A shared area of interest — sexual arousal — does not mean a shared mechanism. A broader account of PT-141 can be found in a separate piece devoted to that peptide.

Safety and limitations

All the information below comes from academic clinical studies on the physiology of the reproductive axis and does not constitute a recommendation to use kisspeptin in humans in the European Union, where the peptide is not registered as a medicine.

In the published studies involving volunteers, kisspeptin administered in a short window, under controlled conditions, was generally well tolerated — the authors reported a favourable profile in acute exposure, with no signals of serious events at the concentrations used in the experiments. This observation, however, applies strictly to research conditions: medical supervision, single or short-term administrations and selected groups of participants.

What the literature does not resolve:

• A lack of data concerning long-term exposure — the studies focused on the acute and short-term response of the axis. The profile under chronic administration remains uncharacterised.
• A lack of validation in the general population — the study participants are selected groups under clinical conditions; there is no basis for transferring the conclusions to use outside the laboratory.
• Unknown consequences of chronic modulation of the HPG axis — because kisspeptin acts at the highest tier of reproductive regulation, the long-term consequences of interfering with this system have not been described.
• A lack of established standards outside the research context — kisspeptin remains a research tool, not an agent with an established profile of use in humans.

In practice, this means a conditional framing: the data suggest good tolerability under narrowly defined experimental conditions, but no material exists justifying safety outside them. In the European Union, kisspeptin remains solely a research reagent.

Kisspeptin as a research reagent

From a laboratory perspective, kisspeptin is an attractive tool for research on the HPG axis precisely because it acts at its highest tier — it allows the response of the entire hormonal cascade to a defined stimulus to be observed. In the One Peptides catalogue, Kisspeptin-10 5 mg is available as a chemical reagent intended for research on KISS1R signalling and the physiology of the reproductive axis in in vitro and animal models.

The analytical standard of the reagent comprises:

• Purity ≥98% determined by RP-HPLC,
• Identity confirmation by mass spectrometry (MS),
• A certificate of analysis (COA) issued for each batch, ensuring traceability of the material from synthesis to delivery.

The reagent is intended solely for laboratory applications — without any therapeutic claims and without any intended use in humans. The reconstitution of the lyophilised material and the preparation of research solutions should be carried out in accordance with the experimental plan and the procedures adopted in the laboratory.

FAQ

Does kisspeptin increase testosterone?

The literature does not permit such a claim. Kisspeptin does not act on testosterone directly — its influence is indirect and proceeds through the HPG axis: stimulation of GnRH neurons leads to an increase in LH secretion, and LH stimulates the Leydig cells to produce testosterone. In the studies, an influence of kisspeptin administration on LH secretion and indirectly on testosterone concentration was observed, but these were primarily observations of an acute, short-term hormonal response under experimental conditions. The data are limited and do not justify treating kisspeptin as an agent that raises testosterone.

Kisspeptin and libido — what does the research say?

Research teams (including the group of Comninos and Dhillo at Imperial College London) studied the influence of kisspeptin on the central processing of stimuli related to sexual arousal, using brain imaging (fMRI). A modulation of the activity of structures involved in the processing of emotions and stimuli of a sexual nature was observed relative to placebo. These are physiological studies of the mechanism, conducted on small groups under controlled conditions — they describe how the system works, rather than confirming any application outside the laboratory.

Kisspeptin and PT-141 — how do they differ?

In mechanism. Kisspeptin acts hormonally, through the HPG axis and the KISS1R (GPR54) receptor, modifying the cascade GnRH → LH/FSH → sex hormones. PT-141 (bremelanotide) acts centrally, through melanocortin receptors (mainly MC4R) in the central nervous system, independently of the hormonal axis. They share an area of research interest (sexual arousal), but they are two distinct signalling systems.

What is the HPG axis?

The HPG axis (hypothalamic–pituitary–gonadal) is a hierarchical hormonal system controlling reproduction. The hypothalamus secretes GnRH (stimulated higher up by kisspeptin), GnRH stimulates the pituitary to secrete the gonadotropins LH and FSH, and these act on the gonads — in men leading to the production of testosterone and spermatogenesis, in women regulating follicle maturation and the production of oestrogens. Sex hormones return as feedback. Kisspeptin serves in this system as the regulator of the highest tier.

Is kisspeptin safe?

In the published clinical studies, kisspeptin administered in a short window, under conditions of medical supervision, was generally well tolerated in acute exposure. This observation, however, applies strictly to research conditions — selected groups and short-term administration. There are no data on long-term exposure or on the consequences of chronic modulation of the HPG axis. In the European Union, kisspeptin is not registered as a medicine or a supplement and remains solely a research reagent (RUO), not intended for use in humans.

Related content

• PT-141 (bremelanotide) — a peptide paired with kisspeptin in the area of sexual arousal, but with a distinct central mechanism (MC4R receptor) independent of the HPG axis.
• Selective androgen receptor modulators (SARMs) — a mechanistic contrast: SARMs act directly on the androgen receptor, whereas kisspeptin modifies the production of sex hormones indirectly, “from the top” of the HPG axis.
• How to recognise high-quality peptides — criteria for assessing a reagent: HPLC purity, MS confirmation, a COA for each batch and material traceability.

Summary

Kisspeptin is a neuropeptide occupying a master position in the hierarchy of the reproductive axis — the signal that “wakes” GnRH neurons and thereby sets in motion the entire hormonal cascade leading to the production of gonadotropins and sex hormones. Its discovery shifted the understanding of the highest tier of reproductive regulation and made it one of the most extensively clinically studied peptides of the HPG axis, with a significant contribution from the group at Imperial College London.

The literature describes the influence of kisspeptin on LH secretion (and indirectly on testosterone), its role in research on fertility and hypothalamic amenorrhoea, applications in the context of assisted reproduction, and the modulation of the central processing of sexual stimuli. These are observations of the mechanism from physiological studies — not a basis for claims about “increasing libido” or “raising testosterone” in humans. The influence on testosterone remains indirect and limited to the acute response of the axis, and the long-term safety profile has not been characterised. In this light, kisspeptin remains above all a tool for studying the physiology of the reproductive axis — and it is solely in such a role, as an RUO reagent, that it appears in the One Peptides catalogue.

Global disclaimer

All One-Peptides products are reagents intended solely for laboratory and scientific research (Research Use Only). They are not medicines, dietary supplements or products intended for human consumption. The information in this article is educational in nature and constitutes a review of the published scientific literature; it does not constitute medical, pharmaceutical or dietary advice.

Bibliography

1. Comninos AN, Dhillo WS et al. (2017). Kisspeptin modulates sexual and emotional brain processing in humans
2. Jayasena CN et al. (2014). Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization
3. George JT et al. (2011). Kisspeptin-10 stimulates LH secretion and the reproductive axis in men
4. Pinilla L, Aguilar E, Dieguez C, Millar RP, Tena-Sempere M (2012). Kisspeptins and reproduction: physiological roles and regulatory mechanisms

Bartosz BartczakPhysiotherapist, Personal Trainer

Physiotherapist with 20 years of clinical experience, graduate of Poznan University of Medical Sciences. Founder of One Peptides and lead author of clinical-perspective content.

See Full Bio ›